CRISPR-delivered anti-BCMA CAR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CRISPR-delivered anti-BCMA CAR-T, covering 2026-03-10 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma [Phase 1]